The art of choosing sound study endpoints

被引:5
作者
Hanson, Beate [1 ]
机构
[1] AO Clin Invest & Documentat, CH-8600 Dubendorf, Switzerland
来源
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED | 2008年 / 39卷 / 06期
关键词
clinical trials; outcome; function; quality of life;
D O I
10.1016/j.injury.2008.02.014
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The selection of appropriate endpoints is the key to successful clinical studies. The chosen primary outcome measure ultimately determines the required sample size, significantly affects trial Logistics, and establishes acceptance of results in the scientific community. Confirmatory statistics may only be conducted on the primary endpoint, white secondary endpoints are better analysed in an exploratory fashion. While investigators may prefer surrogates (e.g., radiographic results, laboratory markers) clinical trials should no longer be planned without addressing function or quality of life. Valid outcome tools (e.g., Short-Form 36) are needed to ensure comparability of findings to other studies. (C) 2008 Published by Elsevier Ltd.
引用
收藏
页码:656 / 658
页数:3
相关论文
共 50 条
  • [21] Defining clinical endpoints in limb girdle muscular dystrophy: a GRASP-LGMD study
    Amy Doody
    Lindsay Alfano
    Jordi Diaz-Manera
    Linda Lowes
    Tahseen Mozaffar
    Katherine D. Mathews
    Conrad C. Weihl
    Matthew Wicklund
    Man Hung
    Jeffrey Statland
    Nicholas E. Johnson
    BMC Neurology, 24
  • [22] Defining clinical endpoints in limb girdle muscular dystrophy: a GRASP-LGMD study
    Doody, Amy
    Alfano, Lindsay
    Diaz-Manera, Jordi
    Lowes, Linda
    Mozaffar, Tahseen
    Mathews, Katherine D.
    Weihl, Conrad C.
    Wicklund, Matthew
    Hung, Man
    Statland, Jeffrey
    Johnson, Nicholas E.
    BMC NEUROLOGY, 2024, 24 (01)
  • [23] Optimal treatment allocation and study duration for trials with discrete-time survival endpoints
    Jozwiak, Katarzyna
    Moerbeek, Mirjam
    JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 2013, 143 (05) : 971 - 982
  • [24] Cancer clinical trials with efficacy and toxicity endpoints: A simulation study to compare two nonparametric methods
    Letierce, Alexia
    Tubert-Bitter, Pascale
    ADVANCES IN STATISTICAL METHODS FOR THE HEALTH SCIENCES: APPLICATIONS TO CANCER AND AIDS STUDIES, GENOME SEQUENCE ANALYSIS, AND SURVIVAL ANALYSIS, 2007, : 335 - +
  • [25] Drug development of nonalcoholic fatty liver disease: challenges in research, regulatory pathways, and study endpoints
    Do, Albert
    Ilagan-Ying, Ysabel C.
    Mehal, Wajahat Z.
    Lim, Joseph K.
    EXPERT OPINION ON DRUG DISCOVERY, 2021, 16 (02) : 125 - 134
  • [26] Tissue-Based Approaches to Study Pharmacodynamic Endpoints in Early Phase Oncology Clinical Trials
    Ang, Joo Ern
    Kaye, Stan
    Banerji, Udai
    CURRENT DRUG TARGETS, 2012, 13 (12) : 1525 - 1534
  • [27] Index and Nonindex Pain Endpoints in Radiation Therapy for Painful Tumors: A Secondary Analysis of a Prospective Observational Study
    Saito, Tetsuo
    Nakamura, Naoki
    Murotani, Kenta
    Shikama, Naoto
    Takahashi, Takeo
    Yorozu, Atsunori
    Heianna, Joichi
    Kubota, Hikaru
    Tomitaka, Etsushi
    Toya, Ryo
    Yamaguchi, Kohsei
    Oya, Natsuo
    ADVANCES IN RADIATION ONCOLOGY, 2020, 5 (06) : 1118 - 1125
  • [28] Probability of Study Success (PrSS) Evaluation Based on Multiple Endpoints in Late Phase Oncology Drug Development
    Zhang, Zhen
    Lin, Yong
    Liu, Jingyi
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2023, 15 (03): : 675 - 688
  • [29] Art therapy in palliative care: A qualitative study
    Rhondali, Wadih
    Chirac, Anne
    Filbet, Marilene
    MEDECINE PALLIATIVE, 2013, 12 (06): : 279 - 285
  • [30] Study Design Characteristics and Endpoints for Enriched Enrollment Randomized Withdrawal Trials for Chronic Pain Patients: A Systematic Review
    Kopsky, David J.
    Szadek, Karolina M.
    Schober, Patrick
    Vrancken, Alexander F. J. E.
    Steegers, Monique A. H.
    JOURNAL OF PAIN RESEARCH, 2022, 15 : 479 - 496